Quest Diagnostics (DGX) Return on Capital Employed (2009 - 2026)

Quest Diagnostics has disclosed Return on Capital Employed across 18 years of filings, most recently posting 11.27% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 11.27%, up 170.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 11.27% (up 170.0% YoY), and the FY2025 annual result was 11.19%, up 77.0% from the prior year.
• Return on Capital Employed came in at 11.27% for Q1 2026 at Quest Diagnostics, up from 11.17% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 18.89% in Q1 2022 to a low of 9.55% in Q3 2023.
• The 5-year median for Return on Capital Employed is 10.65% (2023), against an average of 11.78%.
• Across the five-year window, Return on Capital Employed tumbled 824 bps in 2023 and surged 170 bps in 2026, its largest moves.
• Quest Diagnostics' Return on Capital Employed stood at 12.44% in 2022, then dropped by 15 bps to 10.57% in 2023, then dropped by 9 bps to 9.65% in 2024, then grew by 16 bps to 11.17% in 2025, then grew by 1 bps to 11.27% in 2026.
• The last three Return on Capital Employed figures came in at 11.27% (Q1 2026), 11.17% (Q4 2025), and 10.98% (Q3 2025), per Business Quant data.